[an error occurred while processing this directive]
Skip to Main Content

Latest News

April 15, 2010

Primordial Path To Painkillers

Heat stability of enzyme from Archaea microbe facilitates anti-inflammatory drug synthesis

Carmen Drahl

Chiral ibuprofen precursor
  • Print this article
  • Email the editor

Latest News

October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

Thanks to an enzyme from an ancient microbe, researchers have found new options for making optically pure precursors to familiar painkillers. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are sold as racemic mixtures, even though their biological activity resides in the S enantiomers. The body can convert R versions of NSAIDs to their S forms, but the process isn't equally efficient for all drugs and may be responsible for some side effects. David B. Berkowitz, Paul Blum, and colleagues at the University of Nebraska, Lincoln, have isolated an alcohol dehydrogenase enzyme from a single-celled Archaea microorganism and used the enzyme to transform racemic aldehyde starting materials to S alcohol NSAID precursors (J. Am. Chem. Soc., DOI: 10.1021/ja910778p). Other routes to the chiral precursors exist, but because the archaeal enzyme is heat-stable, the team used higher temperatures and less solvent than is typically needed, with ethanol as a biorenewable reducing agent. The team collects crystallized products by filtration and recycles the enzyme. The work showcases how useful archaeal enzymes can be in asymmetric synthesis, the researchers point out.

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!